Top Medical News
2 hours ago
The combination of androgen deprivation therapy (ADT) with abiraterone acetate and prednisolone (AAP) treatment is effective against metastatic hormone-naïve prostate cancer (mHNPC) regardless of risk stratification, a recent study has shown.
22 hours ago
Smoking intensity is associated with mortality from genitourinary malignancies, according to a nationally representative study. Moreover, the risk of death from bladder and kidney cancers is significantly higher among individuals who started smoking at a younger age and those who smoke at home.
Yesterday
Low skeletal muscle and high fat compositions are independently associated with discharge to a facility following radical cystectomy of nonmetastatic muscle invasive bladder cancer, a study has found.
Yesterday
Higher consumption of animal protein appears to increase the risk of developing kidney stones, according to a study involving a population with a relatively low animal protein intake and a high plant protein intake in Shanghai, China. Increasing the proportion of plant relative to animal protein may protect against this risk.
5 days ago
New drug applications approved by US FDA as of 01 - 15 November 2019 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date. 
5 days ago
Men with higher optimistic action traits are less likely to seek help for psychological needs after being diagnosed with prostate cancer, a new study has found.
12 Nov 2019
Younger men with prostate cancer tend to experience greater psychological distress, a new study has found.
Special Reports
15 Mar 2019
At the Eisai-sponsored tea symposium during the 27th Malaysian Urological Conference at Shangri-La Kuala Lumpur, Professor Osamu Yokoyama highlighted the advantages of silodosin (Urief®, Eisai Inc.) in relieving lower urinary tract symptoms associated with benign prostate hyperplasia.
Conference Reports
Pank Jit Sin, 03 Sep 2019

Immunotherapy, in the setting of advanced prostate cancer (PCa), may alter the lethal condition of advanced PCa into a chronic disease with significantly longer overall survival (OS), says an expert. 
Jackey Suen, 06 Mar 2019

The future of poly(adenosine diphosphate–ribose) polymerase (PARP) inhibitors in the treatment of metastatic castration-resistant prostate cancer (mCRPC) is promising in light of encouraging results from recent clinical studies.

Dr. Joseph Delano Fule Robles, 04 Mar 2019

Since the approval of immune checkpoint inhibitors (ICIs) as standard of care in the second-line setting for metastatic urothelial carcinoma, new approaches on how clinicians manage this condition are emerging.

Dr. Joseph Delano Fule Robles, 22 Feb 2019

Studies have demonstrated that robot-assisted radical cystectomy (RARC) is as effective and has a cost advantage compared with open cystectomy for the management of urologic cancers.

Jackey Suen, 30 Jan 2019

Recent research has revealed various potential biomarkers for metastatic castration-resistant prostate cancer (mCRPC), but several challenges remain in fully utilizing them in clinical practice.

Audrey Abella, 11 May 2018
Nanotechnology structured water was similarly effective as tadalafil in improving erectile function, suggesting that it could be a potential treatment option for erectile dysfunction (ED), according to a study presented at EAU held in Copenhagen, Denmark.
Audrey Abella, 30 Apr 2018
The selective β3-adrenoreceptor (AR) agonist vibegron showed superior efficacy over placebo for overactive bladder (OAB) treatment and was generally well-tolerated, according to a Japanese study presented at EAU 2018.